Evommune, Inc. (EVMN)
20.85
+0.36
(+1.76%)
USD |
NYSE |
Jun 11, 14:49
Evommune Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -124.8% |
| June 30, 2025 | |
| March 31, 2025 | -485.2% |
| Date | Value |
|---|---|
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | -39.77% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Apogee Therapeutics, Inc. | -- |
| Kymera Therapeutics, Inc. | -201.5% |
| Mineralys Therapeutics, Inc. | -- |
| GRAIL, Inc. | -228.5% |
| MapLight Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -48.45% |
| Return on Invested Capital | -52.97% |
| Return on Net Operating Assets | -2.43K% |